Maplight Therapeutics, Inc. (NASDAQ:MPLT) Given Average Recommendation of "Moderate Buy" by Analysts
Maplight Therapeutics, Inc. (NASDAQ:MPLT - Get Free Report) has earned an average recommendation of "Moderate Buy" from the seven research firms that are presently covering the firm, MarketBeat...